Ignite Creation Date:
2025-12-24 @ 4:20 PM
Ignite Modification Date:
2025-12-25 @ 2:16 PM
Study NCT ID:
NCT05269966
Status:
COMPLETED
Last Update Posted:
2025-03-20
First Post:
2022-02-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-09
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-29
Completion Date Type:
ACTUAL
First Submit Date:
2022-02-16
First Submit QC Date:
None
Study First Post Date:
2022-03-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-06-20
Results First Submit QC Date:
None
Results First Post Date:
2024-12-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-18
Last Update Post Date:
2025-03-20
Last Update Post Date Type:
ACTUAL